EIC backs 40 Transition projects from the 2025 call and issues first Seals of Excellence

Brussels, February 9th 2026
Summary
  • 40 Transition projects selected from 611 submissions with grants up to €2.5 million each.
  • For the first time, 228 Seals of Excellence recommend unfunded high quality proposals for other sources.
  • Projects span 17 EU Member States and Horizon Europe associated countries across digital, health, energy, quantum and advanced manufacturing.
  • Selected teams gain Business Acceleration Services and a fast track route to the EIC Accelerator.
  • Next EIC Transition deadline is 16 September 2026.

A new EIC Transition cohort with broader recognition for unfunded proposals

The European Innovation Council selected 40 projects under the 2025 EIC Transition call. Awards provide grants up to €2.5 million per project to validate technology in application relevant environments and to develop credible business plans. The selection came from 611 submissions and includes participants from 17 EU Member States and Horizon Europe associated countries. For the first time in Transition, 228 proposals that met excellence thresholds but could not be funded received a Seal of Excellence to support redirection to national, regional or other EU funding streams.

The portfolio covers a wide range of disciplines. Examples include hardware acceleration for computing on encrypted data, metabolic support to improve embryo development in IVF, and renewable based ammonia synthesis targeted for farm scale demonstration. While the range is welcome, most claims will still require rigorous validation in relevant environments, navigation of regulatory pathways, and credible routes to market adoption.

What EIC Transition funds and where results can originate

EIC Transition projects build on results generated by several EU research instruments and related programmes. These include EIC Pathfinder and its predecessor FET, European Research Council Proof of Concept projects, Research and Innovation Actions funded under Horizon 2020 Societal Challenges and Leadership in Industrial Technologies and under Horizon Europe pillar II, and the European Defence Fund including its Preparatory Action on Defence Research for civil applications including dual use. Funding is devoted to maturing technologies and shaping a business case for specific applications. The selected projects also gain access to Business Acceleration Services for coaching, mentoring and partnering. They are eligible for a fast track scheme to the EIC Accelerator for commercialisation and scale up.

EIC Transition in the EU innovation pipeline:Transition is designed to advance promising research results toward market readiness by supporting validation, demonstration in application relevant environments, and development of a product strategy and business model. It typically addresses the gap between exploratory research and early commercial traction where many EU projects stall.
Technology Readiness Level in this context:While the call text does not fix a starting TRL in this announcement, Transition targets activities like validation and demonstration in relevant settings. In EU practice this often means moving from proof of concept to validated prototypes in realistic use conditions, which is beyond lab scale experimentation.
Eligible sources of results for Transition:Projects can build on results from EIC Pathfinder or FET, ERC Proof of Concept, Horizon 2020 or Horizon Europe R&I actions, and EDF research outputs if focused on civil applications including dual use. This aims to harvest outcomes from upstream EU funded research and bring them closer to market.

Selection metrics and first time Seals of Excellence

The call attracted 611 submissions, 130 of which originated from ERC Proof of Concept projects. The EIC selected 40 for grant preparation. For the first time in Transition, 228 proposals received a Seal of Excellence indicating high quality and recommending support from alternative EU, national or regional funds. In previous EU programmes, uptake of Seals has varied by country and agency, so real world impact depends on whether national or regional programmes reserve budgets to act on these recommendations.

MetricCount or valueComment
Total submissions611Across all fields with no predefined thematic restrictions
Selected projects40Indicative success rate around 6.5 percent
Seal of Excellence228New for Transition to steer good proposals to other funders
Submissions from ERC PoC130Shows strong pipeline from ERC pre-commercial work
Max grant per project€2.5 millionTo validate and demonstrate in application relevant environments
Total budget of selected portfolio€96,420,233.99Sum of listed recommended budgets
Participating countries17EU Member States and associated countries

Highlighted projects and the validation still needed

Encrypted data processing at hardware speed

BELFORT ASIC proposes a hardware accelerator for Fully Homomorphic Encryption to compute on encrypted data without decryption. The team reports speedups up to 2000 times over general purpose processors and compatibility with established FHE software stacks. If verified across standard workloads, this could lower barriers to privacy preserving analytics in finance, health and public sector data.

Fully Homomorphic Encryption explained briefly:FHE enables computation directly on encrypted data. The output decrypts to the same result as if operations were run on plaintext. The approach protects sensitive data during processing but is notoriously compute intensive. Practical adoption depends on algorithmic efficiency, hardware acceleration, software toolchains, and energy and memory overheads.

Healthy skepticism is warranted. Reported speedups depend on workload, precision, scheme parameters and how results compare to high end CPUs and GPUs. Interoperability with libraries like OpenFHE or PALISADE and standardized benchmarking will be important. Energy efficiency, memory bandwidth and integration into secure cloud workflows are likely gating factors for adoption.

Targeting IVF bottlenecks by improving embryo development conditions

OFFSPRING aims to improve IVF outcomes by tailoring culture conditions to the specific metabolic needs of fertilised eggs, shifting focus from selecting the best embryos to improving overall embryo quality. If successful, it would increase the number of viable embryos and potentially reduce the number of cycles needed, cutting costs and stress for patients and clinics.

Claims must be supported by robust clinical evidence. Any medium or protocol changes that influence embryo development will face regulatory scrutiny and will need clear safety and efficacy data. Adoption in clinics depends on reproducibility across patient cohorts and alignment with national regulations on assisted reproduction.

Renewable ammonia production at lower pressure and temperature

EASY looks to advance the Atmonia process to produce ammonia from air and water with renewable electricity and without the high pressure and temperature of Haber Bosch. The team targets a working prototype, on farm demonstration, a market confirmed business plan and a clear permitting pathway for fertilizer and e fuel markets by project end.

Haber Bosch and electrochemical alternatives in context:Conventional ammonia synthesis is capital intensive and energy heavy, typically relying on natural gas. Electrochemical or plasma routes promise decentralised, modular systems powered by renewables. The challenge is to achieve high Faradaic efficiency, current density, and energy per kilogram benchmarks that compete with green Haber Bosch. Safety and permitting for on site ammonia production are non trivial, especially in farming contexts.

Decentralised ammonia is attractive for intermittency and logistics, but scale, cost per tonne, and lifecycle emissions must be proven in field conditions. Regulatory clarity on storage and handling, and access to affordable renewable electricity will determine feasibility.

Portfolio snapshot across deep tech domains

The portfolio spans photonics, quantum and neuromorphic computing, advanced materials, semiconductors and chiplets, biomedical imaging and diagnostics, robotics and automation, climate and industrial processes, and data and software security. Project durations are mostly 24 to 36 months. Budgets cluster near the €2.5 million ceiling, which reflects the cost of integrated validation and market readiness work. A detailed list with acronyms, coordinators, durations and recommended budgets follows.

AcronymTitleDuration (months)Country codeCoordinating organisationRecommended budget
IONPAPIon Conductive Paper-Based Membranes for Flow Batteries, Fuel Cells and Beyond36ATECOLYTE GMBH2,497,063.63 €
MIMIRMiniaturised MEMS-based spectrometers for the Mid-Infrared spectral region36CYCY.R.I.C CYPRUS RESEARCH AND INNOVATION CENTER LTD2,499,968.75 €
ACCESSAffordable Cryo-EM through Computational Enhancement of Structural Studies36NLDELMIC CRYO BV2,498,320.00 €
NEOMAGUNLOCKING INNOVATION OPPORTUNITIES IN MECHANOBIOLOGY AND MECHANOMEDICINE36ES60Nd S.L.2,394,851.97 €
REVOLVREliable animal-free and high-throughput VOLumetric bioprinting of functional 3D assays30CHREADILY3D SA2,117,675.00 €
BELFORT ASICBELFORT ASIC - Pioneering Hardware Acceleration for Computing on Encrypted Data24BEBelfort Labs BV2,480,666.66 €
SPECTRUMAn Integrated Toolkit for Secure Software Development36FRCryspen SARL2,432,017.50 €
SONATASoftware Defined Acoustic Levitation Platform for Lab Automation36UKACOUSTOFAB LTD1,998,703.97 €
LUMENLight-based Ultrafast Modules for Efficient Nanolaser-enhanced processors24FRNCODIN2,498,797.15 €
ARISEAdvanced platform for saRNA production at Industrial Scale in Eukaryotes26FRbYoRNA2,491,875.00 €
SpeedAPPHIGH SPEED AI-DRIVEN ENGINEERING SIMULATIONS FOR ADVANCED PRODUCT DEVELOPMENT32ITFAST COMPUTING SRL SOCIETA' BENEFIT2,431,625.00 €
CLUSTRELSeizure Cluster Relief through Smart Therapeutic Management36ITCONSORZIO INTERUNIVERSITARIO NAZIONALE PER LA SCIENZA E TECNOLOGIA DEI MATERIALI2,494,115.63 €
TAILORFine-Tuning AI Foundation Models for Client-Tailored Long-Range Weather Forecasts30NLBeyond Weather BV2,448,801.78 €
SepTechSepsis Early Prediction Technology36ITBionys S.r.l.2,495,065.90 €
TRU-STACKTransparent Resource Utilisation for Scientific and Enterprise Workloads36ESBARCELONA SUPERCOMPUTING CENTER CENTRO NACIONAL DE SUPERCOMPUTACION2,467,613.55 €
DENOVOSSDe Novo Ossification using human engineered cartilage as cell-free biomaterial36SELUNDS UNIVERSITET2,497,375.03 €
BRIGHTIRBroadband Infrared Emitters for Generalized High-Tech IR Sensing24CH4K-MEMS SA2,499,977.50 €
RE-CLIQSREplaceable Chiplet LInks for Quantum Scaling24NLQUANTWARE B.V.2,499,887.50 €
ELISETEmission Lifetimes technology for sorting, Security and Traceability36ITSINBIOSYS SRL2,253,153.25 €
Lab4DMadeLaboratory 4 Dimensional X-ray Diffraction for Sustainable Materials Development36DKDANMARKS TEKNISKE UNIVERSITET2,491,931.75 €
TRANSPIRETRANsitioning Scalable Photovoltaics with Industrially REliable perovskite module production36BEINTERUNIVERSITAIR MICRO-ELECTRONICA CENTRUM2,493,585.00 €
Q-MSOTQuantitative Multispectral Optoacoustic Tomography36DEHELMHOLTZ ZENTRUM MUENCHEN DEUTSCHES FORSCHUNGSZENTRUM FUER GESUNDHEIT UND UMWELT GMBH2,450,723.00 €
TITANminiaTurized sIlicon phoTonics gAs seNsor-on-chip36SESENSEAIR AB2,448,021.88 €
PI-MOLLPhotonic Integrated Mode-Locked Laser36CHECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE2,500,000.00 €
OFFSPRINGOUTCOME-FOCUSED FERTILITY SOLUTIONS FOR PREIMPLANTATION RESEARCH AND IMPROVED NEONATAL GENESIS18ATdawn-bio GmbH1,804,281.20 €
SHINESuper High-precision Intravascular Near-infrarEd imaging.36ELIDRYMA TECHNOLOGIAS KAI EREVNAS2,499,527.61 €
FALQONFast photonic integrated circuits for continuous-variable quantum key distribution36DKCelare Quantum Communications ApS2,498,823.51 €
PROMPTProficient Robotic Operation for Minimally-invasive Procedural Treatment36BEKATHOLIEKE UNIVERSITEIT LEUVEN2,486,591.00 €
NANOCARRevolutionizing Blood Cancer Therapy: Next-Gen CAR-T Therapy with In Vivo Nanoparticle Targeting24NLNANOCELL THERAPEUTICS BV2,319,487.75 €
SIRENAScalable Integrated Reconfigurable Energy-Efficient Neuromorphic Accelerators36NLUNIVERSITEIT TWENTE2,498,969.75 €
STEMPhageInnovative macrophage therapies to transform treatment paradigm of solid tumors30DETECHNISCHE UNIVERSITAET DRESDEN2,499,935.06 €
ETIAETIA: Causal AI for Data-Driven Insights and Optimal Decision Making36ELPANEPISTIMIO KRITIS2,500,000.00 €
EASIERGraspElectroAdhesion Suction cups for Industrial Energy efficient Robotic Grasping36ITOMNIGRASP SRL2,440,000.00 €
UNILENSUniversal wavefront shaping digital microscope objective lens36ELKYMATONIKI2,112,617.81 €
Spatial FuseseqVolumetric spatial transcriptomics for 3D culture-innovated drug development30SECubase Bio AB1,966,952.50 €
GLIOBREAKDeveloping a new treatment and companion diagnostic to improve outcomes for glioblastoma patients30SEBEACTICA THERAPEUTICS AB2,474,115.24 €
EASYElectrocatalytic Ammonia SYnthesis36ISATMONIA2,495,218.00 €
iNSyT-ONEiNSyT ONE: Real time single particle quality control for quantum dots and nanomaterials36DELUDWIG-MAXIMILIANS-UNIVERSITAET MUENCHEN2,446,942.00 €
DIALOGICTransforming Insurance Communication with DIALOGIC: AI-Driven Clarity, Personalisation, and Compliance for Accessible, Trustworthy Contracts Across Europe’s Digital Insurance Ecosystem24ESINDEEP ARTIFICIAL INTELLIGENCE SL2,500,000.00 €
PARADISEPlAsma technologies for Remediation of Air for a cleaner environment by Development of Innovative microwave Sintered Electroceramics26FRPRODEA DEPOLLUTING2,494,956.16 €

Support services and pathways after the grant

Selected teams are eligible for EIC Business Acceleration Services, which typically include coaching, mentoring, and introductions to corporates, investors and peers. Projects can access a fast track to the EIC Accelerator to finance commercialisation and scaling. This pathway has potential advantages on timing but does not remove the need to pass due diligence and to meet investment and grant criteria.

EIC Accelerator in brief:The Accelerator provides grants and equity or blended finance to help companies scale up. Fast track from Transition can shorten the path to interview and evaluation, but companies must still demonstrate strong market traction potential, credible financial plans, and team capacity to execute.

Risks and bottlenecks to watch

The Seal of Excellence only unlocks impact if national or regional funders activate budgets to support sealed projects. Administrative burdens can discourage applicants from pursuing multiple instruments. The wide disciplinary spread is a strength, but it increases the need for tailored regulatory strategies, from medical devices and advanced therapeutics to chemicals and energy storage. IP management and freedom to operate analysis will be critical as projects move closer to markets. For projects rooted in EDF outcomes, civil focus and dual use considerations must be explicit to avoid procurement or export control issues.

Seal of Excellence purpose and limits:A Seal indicates that a proposal met quality thresholds but could not be funded due to budget limits. It is intended to de risk decision making for other funders. Uptake depends on national policies and available budgets. There is no automatic financing attached to a Seal.

Timeline and next call

The next EIC Transition application deadline is 16 September 2026. Applicants should align technical validation plans with clear market hypotheses, plan for regulatory and certification needs early, and consider how Business Acceleration Services and the Accelerator fast track could be leveraged if milestones are met.